Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal. Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed represented Cenveo in the transaction while O’Melveny represented Brook + Whittle. Brook + Whittle, a leading provider of pressure sensitive and shrink...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard advised Tao Group Hospitality on the deal. Tao Group Hospitality entered into an agreement to acquire majority control of Hakkasan Group, creating a premium...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed LLP represented Greenbriar Equity Group and Nordco in the transaction. Wabtec signed an agreement to purchase Nordco for $400 million in cash, financed...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed LLP represented Spireon in the transaction. CalAmp (Nasdaq: CAMP) and Spireon executed the acquisition of the LoJack® U.S. Stolen Vehicle Recovery (SVR) business from CalAmp. The integration...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed LLP represented ANI Pharmaceuticals in the transaction. ANI Pharmaceuticals signed an agreement to acquire Novitium Pharma for $89.5 million in cash and $74 million...
You must be a Standard 1 Year member to access this content.
DLA Piper LLP (US) served AEye, while Hughes Hubbard & Reed LLP and Ellenoff Grossman & Schole LLP are serving as legal advisors to CF III...
You must be a Standard 1 Year member to access this content.
